DSNKY - Deciphera reaches main goal in Phase 3 trial for rare joint tumor
2023-10-30 07:39:24 ET
More on Deciphera
- Deciphera Pharmaceuticals Pipeline Is Underwhelming
- Deciphera Pharmaceuticals: Clawing Its Way Back
- Deciphera Pharmaceuticals, Inc. (DCPH) Q2 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Deciphera Pharmaceuticals
- Historical earnings data for Deciphera Pharmaceuticals
For further details see:
Deciphera reaches main goal in Phase 3 trial for rare joint tumor